WEBCAST 2 Study:
Extension of WEBCAST study
WEB™ Intrasaccular Embolization
"WEBCAST 2 confirms the high safety and efficacy of WEB aneurysm treatment demonstrated in the WEBCAST and French Observatory studies."
- Patients
55
- Countries
France, Hungary, Germany, Belgium, Denmark
- Clinical Centers
10
- Design
Single arm prospective
- Scope
Patients 18-75 y.o., with wide neck bifurcation intracranial aneurysms ruptured or unruptured, H&H<4, treatable with WEB only
- Purpose
Assessment of safety, efficacy and technical success of WEB to 5 years, including single layer device.
Endpoints
Durability of occlusion at 6 months defined as complete occlusion or stable neck remnant with no worsening from baseline and no retreatment performed or planned (assessed by Corelb)
Efficacy results
At 6 months:
Complete occlusion: 57.1% / Adequate occlusion: 79.6%
At 12 months:
Complete occlusion: 54.0% / Adequate occlusion: 80.0%
Safety results
At 30 days:
Morbidity: 3.6%
Mortality:0%
At 12 months:
Morbidity: 3.9%
Mortality:2%
Study publications
LINK TO STUDY PAGE ClinicalTrials.gov ID NCT01778322
Please refer to Instruction for Use (IFU) in the specific market/country that you are looking into:
Explore more studies
French Observatory Study: WEB™ French Observatory of the WEB Aneurysm Embolization System
WEB™ Intrasaccular Embolization
CLARYS Study: CLinical Assessment of WEB™ Device in Ruptured aneurYSms
WEB™ Intrasaccular Embolization
Request more information
The information you provide through this form is necessary to respond to your request and may be shared with the relevant Terumo Neuro group entity or entities responsible for handling it. For more information on how we process your personal data and on your rights, please refer to our privacy policy.